The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
LLY · Healthcare · Wide moat
On the watchlist
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | RMD | IDXX | LLY | GRMN |
|---|---|---|---|---|
| Moat Score (0–100) | 94 | 96 (highest) | 94 | 94 |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 100 (highest) | 90 | 95 | 95 |
| Pricing power | 96 | 96 | 99 (highest) | 97 |
| Returns on capital | 96 | 100 (highest) | — | 100 (highest) |
| Balance-sheet safety | 100 (highest) | 98 | 83 | 100 (highest) |
| Capital allocation | 77 | 97 | 100 (highest) | 77 |
| 186% above value if growth stopped today (largest discount to value if growth stopped today) | 365% above value if growth stopped today | 1602% above value if growth stopped today | 283% above value if growth stopped today | |
| Market cap | $34.9B | $43.6B | $1.18T | $54.9B |
| Moat tier | Wide moat | Wide moat | Wide moat | Wide moat |
| Filing date | FY2026 | FY2025 | FY2025 | FY2025 |